A study found that the average OS of radiotherapy plus ICIs was significantly longer than that of radiotherapy plus CTLA-4 in patients with malignant melanoma and BMs, which was 27.4 and 7.5 months, respectively [28]. Here, CTLA4 is linked to melanoma.